Galmed Pharma (GLMD.US) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Dec4

Galmed Pharmaceuticals Grants New Use Patent for ARAMCHOL in Combination with Madrigal Pharmaceuticals' REZDIFFRA

13:35

Nov27

Galmed Pharma released FY2025 Q3 earnings on November 26 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3464 (forecast USD -0.54)

04:00

Galmed Pharma released FY2025 9 Months Earnings on November 26 Post-Market (EST), Actual Revenue USD 0, Actual EPS USD -1.5987

04:00

Oct29

Galmed Pharmaceuticals Annual General Meeting Proposals Passed

20:36

Aug29

Galmed Pharma released FY2025 Q2 earnings on August 28 (EST), actual revenue USD 0, actual EPS USD -0.6319 (forecast EPS USD -0.83)

03:00

Galmed Pharma released FY2025 Semi-Annual Earnings on August 28 (EST), actual revenue USD 0, actual EPS USD -1.2554

03:00

Schedules & Filings

Schedules

Filings

Nov26

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -1.892 M, EPS -0.3464

Aug28

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -2.495 M, EPS -0.6319

May22

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -1.104 M, EPS -0.6203

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More